Weekly Work-In-Progress

Presented by:
Tom Handley, MD
Knight-Hennessy Scholar
Stanford University

Title: Cost-effectiveness of Dapagliflozin for Non-Diabetic Chronic Kidney Disease

Bio: Tom Handley is an MD from the UK. He is a Knight-Hennessy Scholar studying for a master’s degree in Health Policy, with specific interests in transplant policy and optimization.

For dial-in instructions, please contact Ana Mezynski at mezynski@stanford.edu